COGNITION THERAPEUTICS INC

Nasdaq:CGTX

Biological Products, (No Diagnostic Substances)·PURCHASE, NY

Cognition encompasses mental processes that deal with knowledge. It includes psychological activities that acquire, store, retrieve, transform, or apply information.

CEO

Ricciardi Lisa

CFO

Doyle John Brendan

Financials

17 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/6/25	→
10-Q	Q2 2025	6/30/25	8/7/25	→
10-Q	Q1 2025	3/31/25	5/7/25	→
10-K	FY 2024	12/31/24	3/20/25	→
10-Q	Q3 2024	9/30/24	11/13/24	→
10-Q	Q2 2024	6/30/24	8/8/24	→
↓

Earnings Releases (8-K)

19 shown

Filed	Period
11/6/25	Q4 FY2025	→
8/7/25	Q3 FY2025	→
5/7/25	Q2 FY2025	→
3/20/25	Q1 FY2025	→
11/13/24	Q4 FY2024	→
8/8/24	Q3 FY2024	→
↓

News (8-K)

45 shown

Filed	Type	Description
3/2/26	Other	Other Events	→
1/27/26	Other	Other Events	→
12/18/25	Agreement	Entry into a Material Definitive Agreement	→
9/15/25	Other	Other Events	→
8/28/25	Agreement	Entry into a Material Definitive Agreement	→
8/26/25	Other	Other Events	→
↓

Prospectuses & Registrations

28 shown

Filed	Form	Description
12/18/25	S-3	S-3	→
8/28/25	424B5	424B5	→
4/28/25	ARS	ARS	→
3/20/25	424B5	424B5	→
3/20/25	S-8	S-8	→
4/26/24	ARS	ARS	→
↓

Filing History(276 filings)

TypeDateAccessionPeriodSize

8-K

Mar 2, 2026

0001104659-26-021904FORM 8-K

Mar 2, 2026

211.5 KB

Feb 18, 2026

0001104659-26-017070OWNERSHIP DOCUMENT

Feb 15, 2026

5.5 KB

Feb 18, 2026

0001104659-26-017068OWNERSHIP DOCUMENT

Feb 15, 2026

4.8 KB

Feb 18, 2026

0001104659-26-017063OWNERSHIP DOCUMENT

Feb 15, 2026

4.8 KB

Feb 5, 2026

0001104659-26-011075OWNERSHIP DOCUMENT

Feb 3, 2026

8.6 KB

Feb 5, 2026

0001104659-26-011074OWNERSHIP DOCUMENT

Feb 3, 2026

6.5 KB

Feb 5, 2026

0001104659-26-011073OWNERSHIP DOCUMENT

Feb 3, 2026

8.0 KB

8-K

Jan 27, 2026

0001104659-26-006813FORM 8-K

Jan 27, 2026

204.9 KB

EFFECT

Dec 23, 2025

9999999995-25-003928

—

1.8 KB

Dec 22, 2025

0001104659-25-123727OWNERSHIP DOCUMENT

Dec 18, 2025

7.4 KB

Dec 22, 2025

0001104659-25-123722OWNERSHIP DOCUMENT

Dec 18, 2025

6.7 KB

Dec 22, 2025

0001104659-25-123721OWNERSHIP DOCUMENT

Dec 18, 2025

6.7 KB

8-K

Dec 18, 2025

0001104659-25-122555FORM 8-K

Dec 16, 2025

190.6 KB

S-3

Dec 18, 2025

0001104659-25-122536S-3

—

1.6 MB

10-Q

Nov 6, 2025

0001104659-25-10740210-Q

Sep 30, 2025

6.0 MB

8-K

Nov 6, 2025

0001104659-25-107390FORM 8-K

Nov 6, 2025

273.9 KB

SCHEDULE 13D/A

Sep 23, 2025

0001104659-25-092675

—

59.0 KB

Sep 23, 2025

0001104659-25-092671OWNERSHIP DOCUMENT

Sep 19, 2025

20.4 KB

8-K

Sep 15, 2025

0001104659-25-089737FORM 8-K

Sep 15, 2025

7.7 MB

8-K

Aug 28, 2025

0001104659-25-084845FORM 8-K

Aug 27, 2025

631.7 KB

424B5

Aug 28, 2025

0001104659-25-084835424B5

—

720.5 KB

8-K

Aug 26, 2025

0001104659-25-083059FORM 8-K

Aug 26, 2025

183.5 KB

8-K

Aug 7, 2025

0001104659-25-075268FORM 8-K

Aug 7, 2025

259.5 KB

10-Q

Aug 7, 2025

0001558370-25-01077110-Q

Jun 30, 2025

5.4 MB

Jul 31, 2025

0001062993-25-013358STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Jul 29, 2025

6.4 KB

25 filings shown

COGNITION THERAPEUTICS INC

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(276 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
4/28/25	DEFA14A	DEFA14A	→
4/28/25	DEF 14A	DEF 14A	→
4/26/24	DEFA14A	DEFA14A	→
4/26/24	DEF 14A	DEF 14A	→
4/24/23	DEFA14A	DEFA14A	→
4/24/23	DEF 14A	DEF 14A	→
↓

Filed	Form	Description
2/18/26	4	OWNERSHIP DOCUMENT	→
2/18/26	4	OWNERSHIP DOCUMENT	→
2/18/26	4	OWNERSHIP DOCUMENT	→
2/5/26	4	OWNERSHIP DOCUMENT	→
2/5/26	4	OWNERSHIP DOCUMENT	→
2/5/26	4	OWNERSHIP DOCUMENT	→
↓

Filed	Form	Description
12/23/25	EFFECT	EFFECT	→
9/23/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
2/4/25	SCHEDULE 13G	SCHEDULE 13G	→
1/8/24	EFFECT	EFFECT	→
1/3/23	EFFECT	EFFECT	→
11/9/22	EFFECT	EFFECT	→
↓